Malignant ophthalmopathy presenting one week after radioiodine treatment of hyperthyroidism

被引：5

作者：

Burmeister, LA

Beatty, RL

Wall, JR

机构：

[1] Univ Pittsburgh, Sch Med, Div Endocrinol & Metab, Dept Med, Pittsburgh, PA 15261 USA

[2] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA

[3] Allegheny Univ Hlth Sci, Dept Med, Pittsburgh, PA USA

来源：

THYROID | 1999年 / 9卷 / 02期

关键词：

D O I：

10.1089/thy.1999.9.189

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

A 46-year-old woman presented with malignant ophthalmopathy 1 week after a therapeutic dose of radioiodine for treatment of hyperthyroidism. The patient was a smoker and had clinical evidence of mild thyroid-associated ophthalmopathy (TAO) prior to treatment with radioiodine. Anti-thyrotropin (TSH) receptor antibodies and antiflavoprotein antibodies were not detected at the time of presentation with malignant ophthalmopathy. The patient responded rapidly to anti-inflammatory treatment with intravenous methylprednisolone and orbital radiation.

引用

收藏

页码：189 / 192

页数：4

相关论文

共 30 条

[1]

EFFECT OF RADIO-IODINE ON STIMULATORY ACTIVITY OF GRAVES IMMUNOGLOBULINS [J].

ATKINSON, S ;

MCGREGOR, AM ;

KENDALLTAYLOR, P ;

PETERSON, MM ;

SMITH, BR .

CLINICAL ENDOCRINOLOGY, 1982, 16 (06) :537-543

[2]

OPHTHALMOPATHY OF GRAVES-DISEASE - OUTCOME AFTER TREATMENT WITH RADIOACTIVE IODINE, SURGERY, OR ANTITHYROID DRUGS [J].

BARBOSA, J ;

WONG, E ;

DOE, RP .

ARCHIVES OF INTERNAL MEDICINE, 1972, 130 (01) :111-&

[3]

Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy [J].

Bartalena, L ;

Marcocci, C ;

Bogazzi, F ;

Manetti, L ;

Tanda, ML ;

Dell'Unto, E ;

Bruno-Bossio, G ;

Nardi, M ;

Bartolomei, MP ;

Lepri, A ;

Rossi, G ;

Martino, E ;

Pinchera, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (02) :73-78

[4]

USE OF CORTICOSTEROIDS TO PREVENT PROGRESSION OF GRAVES OPHTHALMOPATHY AFTER RADIOIODINE THERAPY FOR HYPERTHYROIDISM [J].

BARTALENA, L ;

MARCOCCI, C ;

BOGAZZI, F ;

PANICUCCI, M ;

LEPRI, A ;

PINCHERA, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (20) :1349-1352

[5]

IDENTIFICATION OF A SUBGROUP OF GRAVES-DISEASE PATIENTS AT HIGHER RISK FOR SEVERE OPHTHALMOPATHY AFTER RADIOIODINE [J].

BARTH, A ;

PROBST, P ;

BURGI, H .

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1991, 14 (03) :209-212

[6]

The chronology of Graves' ophthalmopathy in an incidence cohort [J].

Bartley, GB ;

Fatourechi, V ;

Kadrmas, EF ;

Jacobsen, SJ ;

Ilstrup, DM ;

Garrity, JA ;

Gorman, CA .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 1996, 121 (04) :426-434

[7]

CIGARETTE-SMOKING AND THE THYROID [J].

BERTELSEN, JB ;

HEGEDUS, L .

THYROID, 1994, 4 (03) :327-331

[8]

CALISSENDORFF BM, 1986, ACTA OPHTHALMOL, V64, P698

[9]

FERNANDEZSANCHE.JR, 1993, BRIT J SURG, V80, P1134

[10]

GUNJI K, 1998, UNPUB SERUM ANTIBODI